Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anusha Kalbasi

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
Science (New York, N.Y.)|February 19, 2026
Rewiring STAT signaling from the cell surface with Trikine immunotherapeuticsGrayson E Rodriguez, Yang Zhao, Yoko Nishiga, et al.
Cancer Cell|September 11, 2020
Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in MelanomaCatherine S Grasso, Jennifer Tsoi, Mykola Onyshchenko, et al.
Cancer Cell|December 11, 2020
Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in MelanomaCatherine S Grasso, Jennifer Tsoi, Mykola Onyshchenko, et al.
Cancer Discovery|March 5, 2026
Neoadjuvant BO-112 and hypofractionated radiation therapy with or without nivolumab in soft tissue sarcoma: preclinical and phase 1 resultsJie Deng, Aastha Pal, Stefano Testa, et al.
Cancer Discovery|December 29, 2020
Metastasis and Immune Evasion from Extracellular cGAMP HydrolysisJun Li, Mercedes A Duran, Ninjit Dhanota, et al.
The Lancet. Oncology|March 6, 2025
Proceedings of the National Cancer Institute Workshop on combining immunotherapy with radiotherapy: challenges and opportunities for clinical translationZachary S Morris, Sandra Demaria, Arta M Monjazeb, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
Science (New York, N.Y.)|February 19, 2026
Rewiring STAT signaling from the cell surface with Trikine immunotherapeuticsGrayson E Rodriguez, Yang Zhao, Yoko Nishiga, et al.
Cancer Cell|September 11, 2020
Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in MelanomaCatherine S Grasso, Jennifer Tsoi, Mykola Onyshchenko, et al.
Cancer Cell|December 11, 2020
Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in MelanomaCatherine S Grasso, Jennifer Tsoi, Mykola Onyshchenko, et al.
Cancer Discovery|March 5, 2026
Neoadjuvant BO-112 and hypofractionated radiation therapy with or without nivolumab in soft tissue sarcoma: preclinical and phase 1 resultsJie Deng, Aastha Pal, Stefano Testa, et al.
Cancer Discovery|December 29, 2020
Metastasis and Immune Evasion from Extracellular cGAMP HydrolysisJun Li, Mercedes A Duran, Ninjit Dhanota, et al.
The Lancet. Oncology|March 6, 2025
Proceedings of the National Cancer Institute Workshop on combining immunotherapy with radiotherapy: challenges and opportunities for clinical translationZachary S Morris, Sandra Demaria, Arta M Monjazeb, et al.
Pageof 8